Unified Clinical Trial Platform Delivering Patient, Data, and Study Experiences
The life sciences industry is moving away from fragmented, standalone tools and embracing integrated, platform-based solutions. Sponsors, CROs, and sites increasingly demand end-to-end workflows connecting all clinical trial aspects. The Medidata Platform delivers unified capabilities in the form of Patient, Data, and Study Experiences.
The Medidata Experiences
The Medidata Patient, Data, and Study Experiences, delivered on the Medidata Platform and powered by automation and AI, improve patient engagement through digital technologies, enhance data quality with actionable insights, and optimize study design with predictive analytics.
What Sponsors, CROs, and Sites Say About The Medidata Platform
“The transition over to the Medidata Platform has enabled us to follow the provenance of data, from point of collection all the way to monitoring, tracking, and reporting, in a way that we weren’t able to do before. We’ve been able to improve the quality of the data that we’ve been getting out of studies.”
-Jay Jantz, Director of Clinical Data Analytics at Smith & Nephew
“As a mid-size CRO, it’s better for us to promote services that work together in a more seamless fashion; [Medidata] allows us to manage the situation more easily.Having a lot of vendors is not ideal from our perspective because we don’t want to be just seen as a vendor manager that doesn’t have any business running the study.”
-Earl Seltzer, Partnerships and Innovation Lead at CTI
“From a site perspective, we have Medidata Rave EDC, we have RTSM, [and] Safety Gateway. We have Imaging- we can collect imaging from the sites into the system- as well as Site Cloud: End of Study. And it’s not on CDs, it’s just in PDFs- it’s very easy, and there’s an acknowledgement form that’s done electronically. And then all of the patient stuff eConsent, eCOA, and all that stuff we provide that you could run across in your work.”
-Michelle Hartmann, Director, Business Development for South Broward Research
“The full suite of solutions within one platform was the draw for us. We wouldn’t have the complaint [from site partners], “I’m a site in a trial and I have to log into 10 different systems and platforms, and each vendor has its own system with a different login and password.” That’s too complicated for our sites. We minimize the number of platforms that we use for a study- one login, maybe two- reducing complexity and improving usability for sites so that they want to continue to work with us.”
-Christina Villar, Head of Clinical Affairs at Philips
“[Sponsors in the rare disease or biotech space] need cutting edge [solutions] that can adapt to extremely complicated [clinical trials]. The challenges are unique- the patient population is much smaller, but, within the volume of data that you’re collecting, each piece of data that comes in is all the more critical. [Medidata] can consolidate that data into a single platform that analyzes it quickly and can help pivot to changing strategies for a particular clinical program. This is very important.”
-Kathy Zheng, Director Project Management and Clinical Innovations for Prometrika
Fill Out the Form and an Expert Will Reach Out to You Shortly
Contact An Expert
Want to learn more about the Unified Clinical Trial Platform and its components? Fill out the form and a sales representative will be in touch with you.